6-Fluoro-3-methyl-1-benzothiophene-2-carboxylic acid, 97%, 1g

GC capillary column ROTI®Cap-5, 25 m, 0.20 mm, 0.35 µm, 1 Piece(s)

3-(2,4-Difluorophenyl)pentanedioic acid, 95%, 250mg

2-Hydroxy-N-phenylacetamide, 95.0%, 250mg

2-(2,4-Dihydroxyphenyl)-4,6-bis(2,4-dimethylphenyl)-1,3,5-triazine>98.0%(HPLC)(N)5g

2,5-Dichloroisonicotinaldehyde, 95.0%, 5g

Pyrazine-2-carbothioamide, 95+%, 5g

2-chloro-N,N-diphenylacetamide, 98%, 98.0%, 5g

4-BROMO-1H-INDAZOLE-6-CARBONITRILE, 95%, 5g

1-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl-1H-pyrazole, 99.0%, 100g

3-Aminoquinolin-7-ol, 95.0%, 250mg

N-[(1R,2R)-2-Amino-1,2-diphenylethyl]benzenesulfonamide, 97%, 10g

Wide mouth bottle ROTILABO® With UN approval, 250 ml, 45 mm, 20 Piece(s)